Zobrazeno 1 - 10
of 10
pro vyhledávání: '"L J Motloch"'
Autor:
R. M. Gumerov, D. F. Gareeva, P. A. Davtyan, R. F. Rakhimova, T. I. Musin, Sh. Z. Zagidullin, A. E. Pushkareva, M. R. Plotnikova, V. Sh. Ishmetov, V. N. Pavlov, L. J. Motloch, N. Sh. Zagidullin
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 2S (2021)
The coronavirus disease 2019 (COVID-19) affects not only the respiratory system, but also the cardiovascular system in 20-28% of cases, causing endothelial dysfunction, vasculitis, hyper- and hypocoagulation, myocarditis, endothelial dysfunction and
Externí odkaz:
https://doaj.org/article/7a54c836387141ee91668f7910216a44
Autor:
D. F. Gareeva, A. F. Khamitova, I. A. Lakman, R. P. Ronzhin, R. Kh. Zulkarneev, M. R. Plotnikova, E. L. Tulbaev, L. J. Motloch, N. Sh. Zagidullin
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 12 (2020)
A multi-marker approach for assessing the prognosis of patients with ST-segment elevation myocardial infarction (STEMI) is a promising strategy.Aim. To assess the potential prognostic power of soluble growth stimulation gene-2 (sST2), pentraxin 3 (PT
Externí odkaz:
https://doaj.org/article/5a47b0e7d31b4e299e3de3a2f32b6428
Autor:
T Froehling, M Mirna, V Paar, Z Shomanova, V Van Almsick, L J Motloch, D Semo, L Makowski, A Rukosujew, J R Sindermann, H Reinecke, M Lichtenauer, R Pistulli
Publikováno v:
European Heart Journal. 43
Aims Heart failure (HF) remains a major therapeutic and diagnostic challenge. In this study we aimed to analyze the predictive potential of four novel cardiovascular biomarkers – soluble urokinase-type plasminogen activator receptor (suPAR), vascul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c68250125910d5377e92a00f8ea4f023
https://doi.org/10.1093/eurheartj/ehac544.911
https://doi.org/10.1093/eurheartj/ehac544.911
Autor:
B Ohnewein, Z Shomanova, P Jirak, A Topf, E J Froeb, C Pogoda, C Granitz, M Lichtenauer, U Hoppe, H Reinecke, R Pistulli, L J Motloch
Publikováno v:
European Heart Journal. 43
Background Heart Failure with reduced ejection fraction (HFrEF) has a life time risk about 20% among adults aged 40 years or older and a 5-year mortality rate about 60% [1,2]. However novel therapies have shown to improve this outcome. One novel agen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e151bd8cab03cc22360b40a899d722a
https://doi.org/10.1093/eurheartj/ehac544.974
https://doi.org/10.1093/eurheartj/ehac544.974
Autor:
E Boxhammer, M Bellamine, I Szendey, J Kletzer, M Foresti, J Kraus, F Danmayr, A Topf, P Jirak, M Bonsels, M Lichtenauer, U C Hoppe, B Strohmer, L J Motloch, R Larbig
Publikováno v:
European Heart Journal. 43
Background The CASTLE-AF trial in 2018, showed that pulmonary vein isolation provides a survival benefit and a reduced hospitalization rate in patients with heart failure and concomitant atrial fibrillation. Typical atrial flutter (AFL) can also indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9df3ec2dc146c749d010a0a0f058692e
https://doi.org/10.1093/eurheartj/ehac544.460
https://doi.org/10.1093/eurheartj/ehac544.460
Autor:
M C Brandt, E Prinz, W Wintersteller, C Schernthaner, M Hammerer, J Kraus, F Danmayr, B Strohmer, I Pretsch, M Lichtenauer, L J Motloch, U C Hoppe, O Nairz
Publikováno v:
European Heart Journal. 42
Background Interventional cardiologists (IC) are exposed to the highest doses of radiation compared to all other medical specialties. Although head and eyes are exposed to a significant dose of scatter radiation (SCR), precise per-procedure data is s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dcead56650082d613e2ebf6bf556c12f
https://doi.org/10.1093/eurheartj/ehab724.2098
https://doi.org/10.1093/eurheartj/ehab724.2098
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 134:2174-2178
Cryothermal ablation is a new method in cardiac electrophysiology for the percutaneous catheter ablation of cardiac arrhythmias. Cryothermal mapping make possible the functional assessment of a particular site before permanent ablation. In this way t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9db396a8d57919af5cb2eb5d8da1489f
https://doi.org/10.1055/s-0029-1241926
https://doi.org/10.1055/s-0029-1241926
Publikováno v:
Herz. 38(6)
Chronic heart failure has an age-dependent prevalence of 2% and is therefore one of the most frequent diseases in western societies. A reduced hemoglobin concentration according to the definition of the World Health Organization is a common comorbidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3d9829c34ce23c3eeaba23115a718dc6
https://pubmed.ncbi.nlm.nih.gov/23900390
https://pubmed.ncbi.nlm.nih.gov/23900390
Publikováno v:
Der Internist. 52(10)
Cardiotoxicity is a serious side effect of targeted molecular therapies in cancer treatment. Monoclonal antibodies and tyrosine kinase inhibitors are known to be potent therapies in various neoplastic diseases due to inhibition of specific signal tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d124df0a93cc0037d5d62412588e73b4
https://pubmed.ncbi.nlm.nih.gov/21792599
https://pubmed.ncbi.nlm.nih.gov/21792599
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 134(43)
Cryothermal ablation is a new method in cardiac electrophysiology for the percutaneous catheter ablation of cardiac arrhythmias. Cryothermal mapping make possible the functional assessment of a particular site before permanent ablation. In this way t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ef92b546f77e80b15e657a89c6c3f94c
https://pubmed.ncbi.nlm.nih.gov/19826980
https://pubmed.ncbi.nlm.nih.gov/19826980